Published in Women's Health Weekly, August 3rd, 2006
Study 1: Body mass index and hormone therapy interactions correlate with specific breast cancers only.
Investigators at the Fred Hutchinson Cancer Research Center in Seattle conducted a study "to assess interactions between use of estrogen plus progestin hormone therapy (EPHT) and body mass index (BMI) in relation to risks of different types of breast cancer, based on histology and hormone receptor status. We conducted a population-based case-control study that compared 975 postmenopausal breast cancer cases to 1,007 controls."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.